Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DD
176
DELISTED
Du Pont De Nemours E I
DD
| $393M | 0.14% |
6,477,692
+760,527
| +13% | +$51.2M |
2013 Q2
8 quarters
|
|
177
LyondellBasell Industries
LYB
$19.4B
| $393M | 0.14% |
3,791,644
-239,138
| -6% | -$24.1M |
2013 Q2
8 quarters
|
|
178
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $391M | 0.14% |
12,261,496
+920,260
| +8% | +$29.9M |
2013 Q2
8 quarters
|
|
|
DNKN
179
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $390M | 0.14% |
7,091,123
-923,172
| -12% | -$47.8M |
2013 Q2
8 quarters
|
|
180
State Street Technology Select Sector SPDR ETF
XLK
$130B
| $378M | 0.13% |
18,247,642
+2,693,428
| +17% | +$57.5M |
2013 Q2
8 quarters
|
|
181
Fomento Económico Mexicano
FMX
$40.6B
| $377M | 0.13% |
4,232,002
+54,967
| +1% | +$5.1M |
2013 Q2
8 quarters
|
|
182
Regeneron Pharmaceuticals
REGN
$76.9B
| $375M | 0.13% |
734,952
+170,045
| +30% | +$83M |
2013 Q2
8 quarters
|
|
183
Camden Property Trust
CPT
$11.3B
| $373M | 0.13% |
5,020,394
+365,193
| +8% | +$27.6M |
2013 Q2
8 quarters
|
|
184
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$764M
| $365M | 0.13% |
13,599,563
+1,849,284
| +16% | +$54.2M |
2013 Q4
6 quarters
|
|
185
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.7B
| $364M | 0.13% |
1,331,311
+235,414
| +21% | +$65.4M |
2013 Q2
8 quarters
|
|
186
Televisa
TV
$1.16B
| $358M | 0.12% |
9,231,250
-529,192
| -5% | -$19.5M |
2013 Q2
8 quarters
|
|
187
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $357M | 0.12% |
6,775,310
-179,790
| -3% | -$9.48M |
2013 Q2
8 quarters
|
|
|
ENDP
188
DELISTED
Endo International plc
ENDP
| $356M | 0.12% |
4,468,222
-496,915
| -10% | -$42.9M |
2013 Q2
8 quarters
|
|
189
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$44.4B
| $355M | 0.12% |
2,018,925
+377,649
| +23% | +$67.9M |
2013 Q2
8 quarters
|
|
190
Canadian Pacific Kansas City
CP
$74.2B
| $352M | 0.12% |
10,971,345
+2,028,025
| +23% | +$72.4M |
2013 Q2
8 quarters
|
|
191
Vanguard FTSE All-World ex-US ETF
VEU
$68.3B
| $348M | 0.12% |
7,160,701
+1,161,935
| +19% | +$58.9M |
2013 Q2
8 quarters
|
|
192
Citigroup
C
$217B
| $346M | 0.12% |
6,258,982
+328,412
| +6% | +$17.9M |
2013 Q2
8 quarters
|
|
193
Goldman Sachs
GS
$261B
| $343M | 0.12% |
1,641,737
+518,295
| +46% | +$106M |
2013 Q2
8 quarters
|
|
194
eBay
EBAY
$49.9B
| $342M | 0.12% |
13,471,545
-1,501,415
| -10% | -$37.5M |
2013 Q2
8 quarters
|
|
195
EOG Resources
EOG
$77.7B
| $339M | 0.12% |
3,869,165
-482,089
| -11% | -$44.5M |
2013 Q2
8 quarters
|
|
196
Kimco Realty
KIM
$14.9B
| $338M | 0.12% |
15,013,129
+3,762,504
| +33% | +$91.9M |
2013 Q2
8 quarters
|
|
197
iShares TIPS Bond ETF
TIP
$14.2B
| $337M | 0.12% |
3,005,226
+740,064
| +33% | +$83.7M |
2013 Q2
8 quarters
|
|
198
iShares Core US Aggregate Bond ETF
AGG
$136B
| $335M | 0.12% |
3,082,523
-985,005
| -24% | -$108M |
2013 Q2
8 quarters
|
|
199
iShares Russell Mid-Cap Growth ETF
IWP
$20.1B
| $334M | 0.12% |
6,892,736
+482,124
| +8% | +$23.8M |
2013 Q2
8 quarters
|
|
200
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.89B
| $330M | 0.11% |
2,657,836
-32,169
| -1% | -$3.88M |
2013 Q2
8 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.